Ads
related to: Dupixent- Pricing And Insurance
Check Copay Eligibility
Learn About Payment Options
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Getting Started
Instructions For Use
Watch The Video Today!
- Injection Support Center
Get Help With Taking DUPIXENT®
View Injection Resources Now
- Pricing And Insurance
Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 3 hours agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 3 hours agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
New drug therapy ‘highly effective’ for young children with severe eczema
Press Association News via AOL· 2 years agoA new drug therapy to treat moderate to severe eczema in young children has been shown to be “safe...
Sanofi's (SNY) Dupixent Prurigo Nodularis NDA Gets Priority Tag
Zacks via Yahoo Finance· 2 years agoSanofi SNY and partner Regeneron REGN announced that the FDA has accepted their supplemental...
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review
Zacks via Yahoo Finance· 1 year agoSanofi SNY announced that the supplemental biologics license application (sBLA) for the label...
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
Benzinga via Yahoo Finance· 2 years agoASLAN Pharmaceuticals (NASDAQ: ASLN) plans to initiate a new clinical trial of eblasakimab for...
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
Benzinga via Yahoo Finance· 1 year agoThe UK's Medicines and Healthcare Regulatory Agency (MHRA) warned of some new and severe eye-related...
The Most Exciting New Advances in Managing COPD
Time via Yahoo News· 2 months agoCredit - Karl Tapales—Getty Images The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and...
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
Benzinga via Yahoo Finance· 1 year agoThe European Commission approved Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's...
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
Benzinga via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Phase 3 trial of Dupixent...
Ads
related to: Dupixent